Therapy of Hepatitis C - Back to the Future

被引：92
|
作者：
Liang, T. Jake [1 ]
Ghany, Marc G. [1 ]
机构：
[1] NIDDK, NIH, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 370卷 / 21期
关键词：
VIRUS-INFECTION; CHRONIC HCV; SOFOSBUVIR; ABT-450/R-OMBITASVIR; DASABUVIR; LEDIPASVIR; RIBAVIRIN;
D O I：
10.1056/NEJMe1403619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2043 / 2047
页数：5
相关论文
共 50 条
  • [21] Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries
    Ghinea, Narcyz
    Lipworth, Wendy
    Day, Richard
    Hill, Andrew
    Dore, Gregory J.
    Danta, Mark
    LANCET, 2017, 389 (10075): : 1268 - 1272
  • [22] Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
    Kieran, Jennifer Ann
    Norris, Suzanne
    O'Leary, Aisling
    Walsh, Cathal
    Merriman, Raphael
    Houlihan, D.
    McCormick, P. Aiden
    McKiernan, Susan
    Bergin, Colm
    Barry, Michael
    BMC INFECTIOUS DISEASES, 2015, 15
  • [23] Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients
    Peter, Joy
    Nelson, David R.
    LIVER INTERNATIONAL, 2015, 35 : 65 - 70
  • [24] The hepatitis C revolution part 1: antiviral treatment options
    Thiagarajan, Prarthana
    Ryder, Stephen D.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 563 - 571
  • [25] Future studies of combination therapy for chronic hepatitis C: Optimizing response rates for each hepatitis C population
    Main, J
    JOURNAL OF HEPATOLOGY, 1995, 23 : 32 - 36
  • [26] Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection
    Tang, L.
    Ward, H.
    Kattakuzhy, S.
    Wilson, E.
    Kottilil, S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (01) : 21 - 36
  • [27] The beginning of the end: What is the future of interferon therapy for chronic hepatitis C?
    Feld, Jordan J.
    ANTIVIRAL RESEARCH, 2014, 105 : 32 - 38
  • [28] Taribavirin: potential future in the treatment of hepatitis C
    Farrell, Christopher P.
    Mercogliano, Giancarlo
    Navarro, Victor J.
    Rossi, Simona
    FUTURE VIROLOGY, 2011, 6 (02) : 147 - 155
  • [29] What is the future for ribavirin outside of hepatitis C?
    Jeulin, H.
    Kedzierewicz, F.
    Grancher, N.
    Venard, V.
    VIROLOGIE, 2009, 13 (02) : 83 - 92
  • [30] HEPATITIS C Thyroid dysfunction in patients with hepatitis C on IFN-α therapy
    Antonelli, Alessandro
    Ferri, Clodoveo
    Fallahi, Poupak
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (11) : 633 - 635
12345